Back
Cytokinetics Quote, Financials, Valuation and Earnings
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Buy
57
CYTK
Cytokinetics
Last Price:
56.17
Seasonality Move:
-5.12%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Cytokinetics Price Quote
$56.17
-0.58 (-1.02%)
(Updated: September 17, 2024 at 6:55 PM ET)
Cytokinetics Key Stats
Buy
57
Cytokinetics (CYTK)
is a Buy
Day range:
$55.44 - $57.03
52-week range:
$25.98 - $110.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1,839.45
P/B ratio:
61.51%
Volume:
809.4K
Avg. volume:
1.2M
1-year change:
65.79%
Market cap:
$6.7B
Revenue:
$7.5M
EPS:
$-5.37
How Much Does Cytokinetics Make?
-
How Much Are Cytokinetics's Sales Annually?
CYTK Revenues are $7.5M -
How Much Profit Does Cytokinetics's Make A Year?
CYTK net income is -$526.2M
Is Cytokinetics Growing As A Company?
-
What Is Cytokinetics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.71% -
What Is Cytokinetics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Cytokinetics Stock Price Performance
-
Did Cytokinetics Stock Go Up Last Month?
Cytokinetics share price went up by 0.44% last month -
Did CYTK's Share Price Rise Over The Last Year?
CYTK share price rose by 65.79% over the past 1 year
What Is Cytokinetics 52-Week High & Low?
-
What Is Cytokinetics’s 52-Week High Share Price?
Cytokinetics has traded as high as $110.25 over the past 52 weeks -
What Is Cytokinetics’s 52-Week Low Share Price?
Cytokinetics has traded as low as $25.98 over the past 52 weeks
Cytokinetics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Cytokinetics?
-
How Much Debt Does Cytokinetics Have?
Total long term debt quarterly is $655M -
How Much Cash Does Cytokinetics Have?
Cash and short term investments quarterly total is $1.1B -
What Is Cytokinetics’s Book Value Per Share?
Book value per share is 0.92
Is Cytokinetics Cash Flow Positive?
-
What Is CYTK Cash Flow From Operations?
Cash flow from operations (TTM) is -$399.1M -
What Is Cytokinetics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.1B -
What Is Cytokinetics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$627.3M
Cytokinetics Return On Invested Capital
-
Is Management Doing A Good Job?
CYTK return on invested capital is -163.9% -
What Is Cytokinetics Return On Assets?
ROA measures how assets are converting to revenues and is -58.3% -
What Is CYTK Return On Equity?
ROE is a measure of profitability and is 0%
Cytokinetics Earnings Date & Stock Price
-
What Is Cytokinetics's Stock Price Today?
A single share of CYTK can be purchased today for 56.75 -
What Is Cytokinetics’s Stock Symbol?
Cytokinetics trades on the nasdaq under the ticker symbol: CYTK -
When Is Cytokinetics’s Next Earnings Date?
The next quarterly earnings date for Cytokinetics is scheduled on November 1, 2024 -
When Is CYTK's next ex-dividend date?
Cytokinetics's next ex-dividend date is September 18, 2024 -
How To Buy Cytokinetics Stock?
You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Cytokinetics Competitors
-
Who Are Cytokinetics's Competitors?
Below is a list of companies who compete with Cytokinetics or are related in some way:
Cytokinetics Dividend Yield
-
What Is CYTK Dividend Yield?
Cytokinetics’s dividend yield currently is 0% -
What Is Cytokinetics’s Payout Ratio?
Cytokinetics’s payout ratio is 0% -
When Did Cytokinetics Last Pay A Dividend?
The latest dividend pay date is September 18, 2024 -
What Is Cytokinetics’s Dividend Per Share?
Cytokinetics pays a dividend of $0.00 per share
Cytokinetics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -44.38% |
| Revenue: | -71.28% | -98.81% |
Analyst Recommendations
| Buy Recommendations: | 7 |
|---|---|
| Hold Recommendations: | 4 |
| Sell Recommendations: | 0 |
| Price Target: | 81.29 |
| Upside from Last Price: | 43.25% |